| Entry ID |
Original Release date |
Data summary |
Entry Title |
Citation Title |
Authors |
Additional Matches |
| 53129 |
2025-10-08 |
: sets
|
The clinical drug candidate anle138b binds predominantly to a central cavity in lipidic Ab40 fibrils and modulates fibril formation. |
Anle138b binds predominantly to the central cavity in lipidic A\u03b2\u2084\u2080 fibrils and modulates fibril formation
|
Andrei Leonov, Armin Giese, Benedikt Frieg, Bert L de Groot, Christian Dienemann, Christian Griesinger, Dietmar Riedel, Dirk Matthes, Evgeny Nimerovsky, Gunnar F Schroder, Kai Xue, Karin Giller, Kerstin Overkamp, Loren B Andreas, Marianna Stampolaki, Mookyoung Han, Sergey Ryazanov, Stefan Becker | |
| 27065 |
2017-04-27 |
Chemical Shifts: 1 set
|
13C, 15N chemical shift assignments of MAK33 VL S20N amyloid fibrils |
MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.
|
Bernd Reif, Elke Prade, Emma Harding, Johannes Buchner, Kai Xue, Manuel Hora, Riddhiman Sarkar, Vanessa Morris | |
| 25601 |
2015-07-13 |
Chemical Shifts: 1 set
|
Ensemble structure the closed state of Lys63-linked diubiquitin in the absence of a ligand |
Lys63-linked ubiquitin chain adopts multiple conformational states for specific target recognition
|
Chun Tang, Da-Chuan Guo, Ju Yang, Mai-Li Liu, Wei-Ping Zhang, Wen-Kai Zhu, Wen-Xue Jiang, Zhou Gong, Zhu Liu | |
| 15496 |
2008-01-25 |
Chemical Shifts: 1 set
|
Backbone chemical shift assignment of a glutamate receptor ligand binding domain in complexes with five partial agonists |
Backbone chemical shift assignment of a glutamate receptor ligand binding domain in complexes with five partial agonists
|
Michael K Fenwick, Robert E Oswald | Entity name: KAI |
